{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:58:13Z","timestamp":1795064293874,"version":"4.10.2"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Salivary gland secretory carcinoma (SC), previously mammary analog SC, is a low-grade malignancy characterized by well-defined morphology and an immunohistochemical and genetic profile identical to SC of the breast. Translocation t(12;15)(p13;q25) resulting in the <jats:italic toggle=\"yes\">ETV6<\/jats:italic>::<jats:italic toggle=\"yes\">NTRK3<\/jats:italic> gene fusion is a characteristic feature of SC along with S100 protein and mammaglobin immunopositivity. The spectrum of genetic alterations for SC continues to evolve. The aim of this retrospective study was to collect data of salivary gland SCs and to correlate their histologic, immunohistochemical, and molecular genetic data with clinical behavior and long-term follow-up. In this large retrospective study, we aimed to establish a histologic grading scheme and scoring system. A total of 215 cases of salivary gland SCs diagnosed between 1994 and 2021 were obtained from the tumor registries of the authors. Eighty cases were originally diagnosed as something other than SC, most frequently acinic cell carcinoma. Lymph node metastases were identified in 17.1% (20\/117 cases with available data), with distant metastasis in 5.1% (6\/117). Disease recurrence was seen in 15% (n=17\/113 cases with available data). The molecular genetic profile showed <jats:italic toggle=\"yes\">ETV6<\/jats:italic>::<jats:italic toggle=\"yes\">NTRK3<\/jats:italic> gene fusion in 95.4%, including 1 case with a dual fusion of <jats:italic toggle=\"yes\">ETV6<\/jats:italic>::<jats:italic toggle=\"yes\">NTRK3<\/jats:italic> and <jats:italic toggle=\"yes\">MYB<\/jats:italic>::<jats:italic toggle=\"yes\">SMR3B<\/jats:italic>. Less frequent fusion transcripts included <jats:italic toggle=\"yes\">ETV6<\/jats:italic>::<jats:italic toggle=\"yes\">RET<\/jats:italic> (n=12) and <jats:italic toggle=\"yes\">VIM<\/jats:italic>::<jats:italic toggle=\"yes\">RET<\/jats:italic> (n=1). A 3-tiered grading scheme using 6 pathologic parameters (prevailing architecture, pleomorphism, tumor necrosis, perineural invasion (PNI), lymphovascular invasion (LVI), and mitotic count and\/or Ki-67 labeling index) was applied. Grade 1 histology was observed in 44.7% (n=96), grade 2 in 41.9% (n=90), and grade 3 in 13.5% (n=29) of cases. Compared with low-grade and intermediate-grade SC, high-grade tumors were associated with a solid architecture, more prominent hyalinization, infiltrative tumor borders, nuclear pleomorphism, presence of PNI and\/or LVI, and Ki-67 proliferative index &gt;30%. High-grade transformation, a subset of grade 2 or 3 tumors, seen in 8.8% (n=19), was defined as an abrupt transformation of conventional SC into high-grade morphology, sheet-like growth, and a tumor lacking distinctive features of SC. Both overall survival and disease-free survival (5 and 10\u00a0y) were negatively affected by tumor grade, stage, and TNM status (each <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001). SC is a low-grade malignancy with predominantly solid-microcystic growth patterns, driven by a gene fusion, most commonly <jats:italic toggle=\"yes\">ETV6<\/jats:italic>::<jats:italic toggle=\"yes\">NTRK3<\/jats:italic>. There is a low risk for local recurrence and a good overall long-term survival, with a low risk for distant metastasis but a higher risk for locoregional lymph node metastasis. The presence of tumor necrosis, hyalinization, PNI and\/or LVI, and positive resection margins correlate with higher tumor grade, less favorable prognosis, and increased mortality. The statistical results allowed us to design a 3-tiered grading system for salivary SC.<\/jats:p>","DOI":"10.1097\/pas.0000000000002043","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T12:30:52Z","timestamp":1681821052000},"page":"661-677","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":38,"title":["Salivary Gland Secretory Carcinoma"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5829-5572","authenticated-orcid":false,"given":"Martina","family":"Ban\u011b\u010dkov\u00e1","sequence":"first","affiliation":[{"name":"Department of Pathology, Charles University, Faculty of Medicine in Plzen"},{"name":"Bioptic Laboratory Ltd Plzen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester D.R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Head and Neck Pathology Consultations, Woodland Hills, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D.","family":"Hyrcza","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Calgary, Arnie Charbonneau Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Van\u011b\u010dek","sequence":"additional","affiliation":[{"name":"Molecular Genetic Laboratory, Bioptic Laboratory Ltd, Plzen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Laco","sequence":"additional","affiliation":[{"name":"The Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick H.W.","family":"Simpson","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Calgary, Calgary Laboratory Services, Foothills Medical Centre, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Di Palma","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, Department of Histopathology, University of Surrey, Royal Surrey County Hospital, Guildford, Surrey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Brcic","sequence":"additional","affiliation":[{"name":"Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arghavan","family":"Etebarian","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology, School of Dentistry, Alborz University of Medical Sciences, Karaj, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Dimnik","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Majewska","sequence":"additional","affiliation":[{"name":"Department of Pathology, Warmia and Mazury University, Olsztyn"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"St\u00e1rek","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"O\u2019Regan","sequence":"additional","affiliation":[{"name":"Department of Histopathology, St. James\u2019s Hospital & Dublin Dental Hospital, Trinity College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Salviato","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Helliwell","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark\u00e9ta","family":"Hor\u00e1kov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charles University, Faculty of Medicine in Plzen"},{"name":"Bioptic Laboratory Ltd Plzen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Biernat","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical University of Gdansk, Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Onyuma","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kenyatta National Hospital, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charles University, Faculty of Medicine in Plzen"},{"name":"Bioptic Laboratory Ltd Plzen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmo","family":"Leivo","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine, Pathology, University of Turku and Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Skalova","sequence":"additional","affiliation":[{"name":"Department of Pathology, Charles University, Faculty of Medicine in Plzen"},{"name":"Bioptic Laboratory Ltd Plzen"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Skalova","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1535-6108(02)00180-0","article-title":"Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma","volume":"2","author":"Tognon","year":"2002","journal-title":"Cancer Cell"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41467-018-08069-x","article-title":"Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands","volume":"10","author":"Haller","year":"2019","journal-title":"Nat Commun"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/PAS.0000000000001494","article-title":"Nuclear NR4A2 (Nurr1) immunostaining is a novel marker for acinic cell carcinoma of the salivary glands lacking the classic NR4A3 (NOR-1) upregulation","volume":"44","author":"Haller","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/his.14251","article-title":"MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics","volume":"79","author":"Taverna","year":"2021","journal-title":"Histopathology"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2559.2012.04232.x","article-title":"Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands","volume":"61","author":"Chiosea","year":"2012","journal-title":"Histopathology"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/PAS.0000000000000088","article-title":"Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR, and CCND1 genes","volume":"38","author":"Skalova","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11523-018-0590-1","article-title":"TRK inhibition: a new tumor-agnostic treatment strategy","volume":"13","author":"Kummar","year":"2018","journal-title":"Target Oncol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"viii23","DOI":"10.1093\/annonc\/mdz282","article-title":"TRK inhibitors in TRK fusion-positive cancers","volume":"30","author":"Drilon","year":"2019","journal-title":"Ann Oncol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ajo.2018.06.019","article-title":"Primary secretory carcinoma of the lacrimal gland: report of a new entity","volume":"193","author":"Hyrcza","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12105-016-0715-8","article-title":"A case of primary mammary analog secretory carcinoma (MASC) of the thyroid masquerading as papillary thyroid carcinoma: potentially more than a one off","volume":"10","author":"Reynolds","year":"2016","journal-title":"Head Neck Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/modpathol.2016.115","article-title":"Mammary analog secretory carcinoma of the thyroid gland: a primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion","volume":"29","author":"Dogan","year":"2016","journal-title":"Mod Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/PAS.0b013e3181e4f49d","article-title":"Mammary-type secretory carcinoma of the skin","volume":"34","author":"Kazakov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.mpdhp.2015.10.003","article-title":"Detection of the ETV6-NTRK3 translocation in cutaneous mamary-analogue secretory carcinoma","volume":"21","author":"Hyrcza","year":"2015","journal-title":"Diagn Histopathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PAS.0000000000000734","article-title":"Secretory carcinoma of the skin harboring ETV6 gene fusions: a cutaneous analogue to secretory carcinomas of the breast and salivary glands","volume":"41","author":"Bishop","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/PAS.0000000000001261","article-title":"Secretory carcinoma of the skin: report of 6 cases, including a case with a novel NFIX-PKN1 translocation","volume":"43","author":"Kastnerova","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/his.12702","article-title":"Mammary analogue secretory carcinoma of the sinus ethmoidalis","volume":"67","author":"Lurquin","year":"2015","journal-title":"Histopathology"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/PAS.0000000000001048","article-title":"Mammary analog secretory carcinoma of the nasal cavity: characterization of 2 cases and their distinction from other low-grade sinonasal adenocarcinomas","volume":"42","author":"Baneckova","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.humpath.2017.10.027","article-title":"Primary mammary analogue secretory carcinoma of the lung: a case report","volume":"74","author":"Huang","year":"2018","journal-title":"Hum Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/PGP.0000000000000501","article-title":"Primary mammary analog secretory carcinoma (MASC) of the vulva with ETV6-NTRK3 fusion: a case report","volume":"38","author":"Nguyen","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1097\/PGP.0000000000000670","article-title":"Secretory carcinoma (mammary analogue secretory carcinoma) of the vulva with ETV6 gene rearrangement: a brief report with follow-up","volume":"40","author":"Baban","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R22-20250608","first-page":"5046","article-title":"ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma","volume":"58","author":"Knezevich","year":"1998","journal-title":"Cancer Res"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng0298-184","article-title":"A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma","volume":"18","author":"Knezevich","year":"1998","journal-title":"Nat Genet"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1746-1596-6-19","article-title":"Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia","volume":"6","author":"Kralik","year":"2011","journal-title":"Diagn Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/his.12910","article-title":"ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours","volume":"69","author":"Yamamoto","year":"2016","journal-title":"Histopathology"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41379-020-0623-z","article-title":"Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST)","volume":"34","author":"Atiq","year":"2021","journal-title":"Mod Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cncr.28484","article-title":"ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer","volume":"120","author":"Leeman-Neill","year":"2014","journal-title":"Cancer"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/PAS.0000000000000392","article-title":"Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion","volume":"39","author":"Ito","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/PAS.0000000000000537","article-title":"Mammary analogue secretory carcinoma of salivary glands: molecular analysis of 25 ETV6 gene rearranged tumors with lack of detection of classical ETV6-NTRK3 fusion transcript by standard RT-PCR: report of 4 cases harboring ETV6-X gene fusion","volume":"40","author":"Skalova","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0000000000000972","article-title":"Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases","volume":"42","author":"Skalova","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"101911","DOI":"10.1016\/j.ctrv.2019.101911","article-title":"RET fusions in solid tumors","volume":"81","author":"Li","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/PAS.0000000000001065","article-title":"Salivary secretory carcinoma with a novel ETV6-MET fusion: expanding the molecular spectrum of a recently described entity","volume":"42","author":"Rooper","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.humpath.2018.08.011","article-title":"Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family","volume":"83","author":"Guilmette","year":"2019","journal-title":"Hum Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/PAS.0000000000001471","article-title":"Salivary secretory carcinoma harboring a novel ALK fusion: expanding the molecular characterization of carcinomas beyond the ETV6 gene","volume":"44","author":"Sasaki","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/PAS.0000000000001535","article-title":"Expanding the molecular spectrum of secretory carcinoma of salivary glands with a novel VIM-RET fusion","volume":"44","author":"Skalova","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41379-019-0427-1","article-title":"Characterization of novel genetic alterations in salivary gland secretory carcinoma","volume":"33","author":"Na","year":"2020","journal-title":"Mod Pathol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.oraloncology.2018.04.022","article-title":"Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands","volume":"82","author":"Boon","year":"2018","journal-title":"Oral Oncol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hed.25536","article-title":"Secretory carcinoma of the major salivary gland: provincial population-based analysis of clinical behavior and outcomes","volume":"41","author":"Ayre","year":"2019","journal-title":"Head Neck"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamaoto.2018.2936","article-title":"Analysis of clinical features of mammary analog secretory carcinoma using the Surveillance, Epidemiology, and End Results Database","volume":"145","author":"Anderson","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.oooo.2020.04.007","article-title":"A systematic review of secretory carcinoma of the salivary gland: where are we?","volume":"132","author":"Alves","year":"2021","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/his.14772","article-title":"Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors","volume":"81","author":"Xu","year":"2022","journal-title":"Histopathology"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.joms.2019.01.002","article-title":"Higher Ki67 index, nodal involvement, and invasive growth were high risk factors for worse prognosis in conventional mammary analogue secretory carcinoma","volume":"77","author":"Sun","year":"2019","journal-title":"J Oral Maxillofac Surg"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/019459988809800210","article-title":"Dedifferentiated acinic cell (acinous) carcinoma of the parotid gland","volume":"98","author":"Stanley","year":"1988","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/PAP.0000000000000298","article-title":"High-grade transformation\/dedifferentiation in salivary gland carcinomas: occurrence across subtypes and clinical significance","volume":"28","author":"Skalova","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/modpathol.2015.64","article-title":"Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study","volume":"28","author":"Stevens","year":"2015","journal-title":"Mod Pathol"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-014-1701-8","article-title":"Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement","volume":"466","author":"Majewska","year":"2015","journal-title":"Virchows Arch"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.prp.2012.12.005","article-title":"Mammary analog secretory carcinoma of salivary glands: a report of 2 cases with expression of basal\/myoepithelial markers (calponin, CD10 and p63 protein)","volume":"209","author":"Laco","year":"2013","journal-title":"Pathol Res Pract"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.4317\/medoral.19874","article-title":"Mammary analogue secretory carcinoma (MASC) of salivary gland in four Mexican patients","volume":"20","author":"Serrano-Arevalo","year":"2015","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00000478-200107000-00001","article-title":"Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading","volume":"25","author":"Brandwein","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/1097-0142(197807)42:1<265::AID-CNCR2820420141>3.0.CO;2-Z","article-title":"Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course","volume":"42","author":"Perzin","year":"1978","journal-title":"Cancer"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/1097-0142(19840915)54:6<1062::AID-CNCR2820540622>3.0.CO;2-E","article-title":"Histologic grading of adenoid cystic carcinoma of the salivary glands","volume":"54","author":"Szanto","year":"1984","journal-title":"Cancer"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0002-9610(74)90265-7","article-title":"Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases","volume":"128","author":"Spiro","year":"1974","journal-title":"Am J Surg"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.oraloncology.2014.10.007","article-title":"Histopathological grading of adenoid cystic carcinoma of the head and neck: analysis of currently used grading systems and proposal for a simplified grading scheme","volume":"51","author":"van Weert","year":"2015","journal-title":"Oral Oncol"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1007\/s00405-015-3855-7","article-title":"Salivary acinic cell carcinoma: reappraisal and update","volume":"273","author":"Vander Poorten","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R56-20250608","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/lary.24231","article-title":"Demographic trends and disease-specific survival in salivary acinic cell carcinoma: an analysis of 1129 cases","volume":"124","author":"Patel","year":"2014","journal-title":"Laryngoscope"},{"key":"R57-20250608","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1158\/1055-9965.EPI-09-0638","article-title":"Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States","volume":"18","author":"Boukheris","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R58-20250608","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PAS.0b013e318242a5b0","article-title":"The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma","volume":"36","author":"Chiosea","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R59-20250608","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/hed.24755","article-title":"Systematic review of mammary analog secretory carcinoma of salivary glands at 7 years after description","volume":"39","author":"Khalele","year":"2017","journal-title":"Head Neck"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:00:17Z","timestamp":1749416417000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002043"}},"subtitle":["Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System"],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002043","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}